Price Target Updated: Feb 15, 2025 20.0065.00110.00155.00199.93Past 12 Months12 Months ForecastMax96.00Avg49.29Min25.00Current 32.99 Unlock Price Targets Trade Overview Unit: M Net Inflow17.03 7.07%12.06%10.13%18.79%18.27%10.25%14.23%9.22% Inflow:225.41 Outflow:208.38 39.98 XL 30.66 61.75 L 52.30...
Biotech and PharmaModerna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. Jan. 13, 2025 at 8:51 a.m. ETby Barron's Moderna Inc. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the fol...
Moderna (MRNA) adaptive stock price forecast & ideologically balanced news. Transparently evaluate AI model performance.
Current Price ▲39.630 USD 7 Days Forecast Get It Now! 1-Year Forecast* ▼0.000000143 USD Historical index on US Stock Market :A+"Should I invest inModernastock?" "Should I trade "MRNA" stock today?"According to our live Forecast System,Moderna Incstock is abadlong-term (1-year)investme...
*Stock Advisor returns as of November 4, 2024 Stephane V. Bancel--Chief Executive Officer Thank you, Lavina. Good morning or good afternoon, everyone. Thank you for joining us. I will start with a review of our business in the third quarter. ...
with cash cost estimations projected to drop by around $1bn from 2024. The company’s stock was down 21% when the market opened that day [13 January] and remains in the same range a day later. Moderna, which took centre stage during the pandemic, has not had a share price this low ...
Moderna is counting on its product pipeline to resuscitate its ailing stock Feb. 14, 2025 at 5:16 p.m. ETby Ciara Linnane TechnologyThese Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More ...
Biotech and PharmaModerna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. Jan. 13, 2025 at 8:51 a.m. ETby Barron's Biotechs active in premarket trade Jan. 13, 2025 at 7:38 a.m. ETby Steve Goldstein Biotech and PharmaThere’s a ‘Shadow’ Over Biotech Stocks. Why It...